Gherlin expression in women with polycystic ovary syndrome - A preliminary study

European Journal of Gynaecological Oncology

Volumn 26, Issue 5, 2005, Pages 553-556

  Skommer, J ^a   Katulski, K ^b   Poreba E ^a   Meczekalski B ^b   Slopien R ^b   Plewa, R ^a   Gozdzicka Jozefiak A ^a   Warenik Szymankiewicz, A ^b  

^a ADAM MICKIEWICZ UNIVERSITY   (Poland)

^b POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Ghrelin expression; PCOS

Indexed keywords

GHRELIN; MESSENGER RNA;

ADULT; ARTICLE; BLOOD CELL; CASE REPORT; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; OVARY FUNCTION; OVARY POLYCYSTIC DISEASE; REAL TIME POLYMERASE CHAIN REACTION;

ADULT; CASE-CONTROL STUDIES; FEMALE; HUMANS; POLYCYSTIC OVARY SYNDROME; RECEPTORS, G-PROTEIN-COUPLED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 27744555957     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Dunaif A., Givens J.R., Haseltine R, Merriam G.R.: "The Polycystic Ovary Syndrome". Cambridge, MA, Blackwell Scientific, 1992.
2. Farquhar C.M., Birdsall M, Manning P., Mitchell J.M., France J.T.: "The prevalence of polycystic ovaries on ultrasound scanning in a population of randomly selected women". Aust. NZJ. Obstet. Gyneacol., 1994, 34, 67.
3. Dong J., Albertini D.F., Nishimori K., Kumar T.R., Lu N., Matzuk M.M.: "Growth differentiation factor-9 is required during early ovarian follliculogenesis". Nature, 1996, 383, 531.
4. Teixeira Filho F.L., Baracat E.G., Lee T.H., Suh C.S., Matsui M. et al: "Aberrant expression of growth differentiation factor-9 in oocytes of women with polycystic ovary syndrome". J. Clin. Endocrinol. and Metab., 2002, 87, 1337.
5. Heinonen S., Korhonen S., Helisalmi S., Koivunen R., Tapanainen J.S., Laakso M.: "The 121Q allele of the plasma cell membrane glycoprotein 1 gene predisposes to polycystic ovary syndrome". Fertil. Steril, 2004, 82, 743.
6. Jansen E., Laven J.S., Dommerholt H.B., Polman J., van Rijt C., van der Hurk C. et al: "Abnormal gene expression profiles in human ovaries from polycystic ovary syndrome patients". Mol. Endocrinol, 2004, 18, 3050.
7. Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H., Kangawa K.: "Ghrelin is a growth-hormone-releasing acylated peptide from stomach". Nature, 1999, 99, 141.
8. Karbonits M., Kojima M., Kangawa K., Grossman A.B.: "Presence of ghrelin in normal and adenomatous human pituitary". Endocrine, 2001, 14, 101.
9. Wierup N., Svensson H., Mulder H., Sundler F. et al: "The ghrelin cell: a novel developmentally regulated islet cell in the human pancreas" Regulatory Peptides, 2002, 707, 63.
10. Tena-Sempere M., Barreiro M.L., Gonzales L.C.: "Novel expression and functional role of ghrelin in rat testis". Endocrinology, 2002,143, 717.
11. Poison D.W., Adams J., Wadsworth J., Franks S.: "Polycystic ovaries - a common finding in normal women". Lancet, 1988, 1, 870.
12. Horvarh T.L., Diano S., Sotonyi P., Meiman M., Tschop M.: "Minireview. Ghrelin and the regulation of energy balance -a hypothalamic perspective". Endocrinology, 2001, 142, 4163.
13. Korner J., Aronne LJ.: "The emerging science of body weight regulation and its impact on obesity treatment". Clin. Invest., 2003, 111, 565.
14. Zawadski J.K., Dunaif A.: "Diagnostic criteria for polycystic ovary syndrome: Towards a rational approach". In: Dunaif A., Givens J.R., Haseltine P.P., Merriam G.R. (eds.), Current Issues in Endocrinology and Metabolism. Polycystic Ovary Syndrome. Boston, Blackwell Scientific, 1992, 377.
15. Waśko R., Komarowska H., Warenik-Szymankiewicz A., Sowiński J.: "Elevated ghrelin plasma levels in patients with polycystic ovary syndrome". Harm. Metab. Res., 2003, 36, 170.
16. Korbonits M., Bustin S.A., Kojima M., Jordan S., Adams E.F., Lowe D.G. et al. : "The expression of the growth hormone secretagogue receptor ligand ghrelin in normal and abnormal pituitary and other neuroendocrine tumors". J. Clin Endocrinol. Metab., 2001, 86, 881.
17. Morrison T.B., Weis J.J., Wittwer C.T.: "Quantification of low-copy transcripts by continuous SYBR Green I monitoring during amplification". Biotechniques, 1998, 24, 945.
18. Ririe K.M., Rasmussen R.P., Witwer C.T.: "Product differentiation by analysis of DNA melting curves during the polymerase chain reaction". Anal. Biochem., 1997, 245, 154.
19. Schofl C., Horn R., Schll T., Schlosser H.W., Muller M.J., Brabant G.: "Circulating ghrelin levels in patients with polycystic ovary syndrome". J. Clin. Endocrinol. Matab., 2002, 42, 635.
20. Orio F. Jr., Lucidi P., Palomba S., Tauchmanova L., Cascella T., Russo T. et al.: "Circulating ghrelin concentrations in polycystic ovary syndrome". J. Clin. Endocrinol. Metab., 2003, 88, 942.
21. Pagotto U., Gambineri A., Vicennati V., Heiman M.L., Tschop M., Pasquali R.: "Plasma ghrelin, obesity, and polycystic ovary syndrome". J. Clin. Endocrinol. Metab., 2002, 87, 5625.
22. Horvath T.L., Diano S., Sotonyi P., Heiman M., Tschop M.: "Mini review: ghrelin and the regulation of energy balance - A hypothalamic perspective". Endocrinology, 2001, 142, 4163.
23. Wren A.M., Small C.J., Abbott C.R., Dhillo W.S., Seal L.J., Cohen M.A. et al.: "Ghrelin causes hyperphagia and obesity in rats". Diabetes, 2001, 50, 2540.
24. Gaytan E, Barreiro M.L., Chopin L.K., Herington A.C., Morales C., Pinilla L. et al.: "Immunolocalization of ghrelin and its Functional receptor, the type 1a growth hormone secretagogue receptor, in the cystic human ovary". J. Clin. Endocrinol. Metab., 2003, 88, 879.
25. Caminos J.E., Tena-Sempere M., Gaytan F., Sanchez-Criado J.E., Barreiro M.L., Nogueiras R. et al: "Expression of ghrelin in the cystic and pregnant rat ovary". Endocrinology, 2003, 14494, 1594.
26. Date Y, Nakazato M., Hashiguchi S., Dezaki K., Mondal M.S., Hosoda H. et al.: "Ghrelin is present in pancreatic alfa-cells of humans and rats and stimulates insulin secretion". Diabetes, 2002, 5, 124.
27. Gambineri A., Pagotto U., Tschop M., Vicennati V., Manicardi E., Carcello A. et al: "Anti-androgen treatment increeeases circulating ghrelin levels in obese women with polycystic ovary syndrome". J. Endocrinol. Invest., 2003, 26, 629.